Right ventricular dysfunction sepsis-induced cardiomyopathy

1 paper1 finding

Humans1

Interventions

1

GLP-1 receptor agonists

no changein humans1

1 study

GLP-1 receptor agonists have no effect on right ventricular dysfunction sepsis-induced cardiomyopathy in humans.
Humansin adults with type 2 diabetes mellitus and infection1 year
Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study
Frontiers in pharmacology31 Jul 2026

More on GLP-1 receptor agonists

Latest

1 in 12 months

Frontiers in Pharmacology15 Aug

Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study

Cohort study of 189,156 peopleCardiomyopathy